Q3 2025 Earnings Call November 5, 2025 8:30 AM ESTCompany ParticipantsAlex Giaimo - Head of Investor RelationsMatthew Bromberg ...
Q3 2025 Earnings Call November 5, 2025 10:00 AM ESTCompany ParticipantsShane Kleinstein - Head of Investor RelationsDerek Chang ...
This study offers a valuable advance for neuroscience by extending a visualization tool that enables intuitive assessment of how dendritic and synaptic currents shape the output of neurons. The ...
Opioid deprescribing is advised when risks of opioid use outweigh benefits. A tailored, patient-centered plan with gradual dose reduction, monitoring, and support can improve outcomes and reduce harm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback